- The Hong Kong stock market shows polarized capital flows this week, with institutional investors shifting from defensive sectors to high volatility technology derivatives.
- CSOP (7788.HK) will adjust its Nvidia daily leveraged products starting August 3, 2026, using a flexible leveraged structure capped at 2x to reduce single-day friction costs.
- Fosun Pharma (2196.HK) stabilized this year as its subsidiary received phase I clinical approval for Parkinson's drug DM1001 in late July 2026.
